Search Results

You are looking at 81 - 90 of 1,457 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

Sexual Health Is Paramount in the Counseling of Women at Risk for Breast or Ovarian Cancer Undergoing Risk-Reducing Surgery

Jordan E. Rullo and Sandhya Pruthi

preoperatively. 2 For women undergoing risk-reducing surgeries for elevated breast or ovarian cancer risk or hereditary predisposition, the impact on sexual health is one of the most influential factors when deciding to undergo these surgeries. 3 Among BRCA

Full access

Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer

Andrea Cercek, Karyn A. Goodman, Carla Hajj, Emily Weisberger, Neil H. Segal, Diane L. Reidy-Lagunes, Zsofia K. Stadler, Abraham J. Wu, Martin R. Weiser, Philip B. Paty, Jose G. Guillem, Garrett M. Nash, Larissa K. Temple, Julio Garcia-Aguilar, and Leonard B. Saltz

those of local recurrence. 1 , 2 The current standard management for stage II (T3/T4N0) and stage III (TanyN1/N2) rectal cancer is neoadjuvant chemoradiotherapy, followed by surgery, with 4 months of adjuvant systemic chemotherapy given at the end. 1

Full access

CLO23-050: Total Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric Cancer

Veronika Patsko, Oleksii Dobrzhankiy, and Yurii Kondratsky

: Complex treatment that includes neoadjuvant chemotherapy, surgery and HIPEC showed to be safe for patients with locally advanced gastric cancer. Total neoadjuvant chemotherapy and HIPEC did not show any increase in adverse reactions associated with

Full access

Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population

Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta

Background Delays in delivery of care for head and neck squamous cell carcinoma (HNSCC) can increase risk of disease persistence or progression. 1 , 2 Among the various delay intervals in HNSCC treatment, delayed time from surgery to

Full access

BPI24-021: Impact of Social Determinants (SDOH) on Surgery and Patient Outcomes in Early-Stage Non–Small Cell Lung Cancer (eNSCLC)

Atharv Sharma, Manu Prasad, Tianyuan Hu, Arunav Saikia, Prabhakar Gaur, Venkata Sai Sumanth Pulluri, and Stuti Jha

Background: Disparities in eNSCLC treatment related to SDOH factors are a significant concern. This study used real-world data to assess how SDOH impacts patient outcomes and the time taken to receive surgery. Method: The study included 18

Full access

CLO22-094: Leg Length Discrepancy Following Limb Sparing Surgery in Pediatric and Adolescent Lower Extremity Bone Sarcomas: A Case Series

Angela W Zhang, Camille M Powers, Kathryn E Gallaway, and Alexandra K Callan

Background : Leg length discrepancy (LLD) is a potential long-term complication in skeletally immature patients with lower extremity bone tumors undergoing limb salvage surgery. Surgical reconstruction violates the epiphyseal plates around the

Full access

HSR20-085: Real-World Study of Factors Associated With Breast Conserving Surgery for Females Diagnosed With Early Stage Breast Cancer

Judy George, Joseph Tkacz, M. Christopher Roebuck, Fredy Reyes, Yull E. Arriaga, Gretchen P. Jackson, and Irene Dankwa-Mullan

Background: Breast Conserving Surgery (BCS) is now considered an acceptable alternative to mastectomy for patients with early stage invasive breast cancer (ESBCa). Limited research examining factors influencing choice of BCS reveal important

Full access

Merkel Cell Carcinoma: A Population Analysis on Survival

Vishwajith Sridharan, Vinayak Muralidhar, Danielle N. Margalit, Roy B. Tishler, James A. DeCaprio, Manisha Thakuria, Guilherme Rabinowits, and Jonathan D. Schoenfeld

also abstracted treatment parameters, including cancer-directed surgery at the primary site, SLNB and/or lymph node removal, and use of RT. The SEER database codes for SLNB are included with codes for lymph node–specific surgery; there is limited

Full access

Receipt of Guideline-Concordant Care Among Older Women With Stage I–III Breast Cancer: A Population-Based Study

Traci LeMasters, S. Suresh Madhavan, Usha Sambamoorthi, Hannah W. Hazard-Jenkins, Kimberly M. Kelly, and Dustin Long

) following breast-conserving surgery (BCS) for patients aged ≥70 years with stage I, estrogen receptor (ER)–positive breast cancer and that they should receive adjuvant endocrine therapy (AET) based on the CALGB C9343 trial findings. 2 , 10 , 11 The second

Full access

CLO23-065: Dosimetric Comparison of Hypofractionation With Concomitant Boost Versus Sequential Boost Following Breast-Conserving Surgery in Early Stage Breast Cancer Patients

Joy Ogunmuyiwa, Hanaan Habibulla, Haoyu Wang, Onyinye Balogun, and Hani Ashamalla

Background: For breast cancer patients, radiation remains a cornerstone of breast conserving therapy (BCT). Hypofractionation is the clinical standard of care for a select group of early breast cancer patients following breast conserving surgery